Transplantation of Conditionally Immortalized Hepatocytes to Treat Hepatic Encephalopathy
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Transplantation of hepatocytes has been shown to provide metabolic support during liver failure in experimental models. The potential clinical application of hepatocyte transplantation, however, is limited by the need for readily available, well–characterized cells, and a worldwide shortage of donor organs. A clonal hepatocyte cell line that could be grown economically in vitro and would exhibit a differentiated, nontransformed phenotype following transplantation would be an attractive solution to this problem. To test this alternative, primary Lewis rat hepatocytes were conditionally immortalized by retroviral transduction with a thermolabile mutant Simian virus 40 (SV40) large T antigen. The cloned immortalized cells proliferate in culture at 33 degrees C and stop growing at 37 degrees C to 39 degrees C. Transplanted into normal livers, these hepatocytes integrate normally into liver cords. When transplanted into the spleens of portacaval–shunted rats, they protect recipients from hyperammonemia–induced hepatic encephalopathy. The cells engrafted in the spleen exhibit normal morphology, secrete bile, and express albumin messenger RNA. The protection from hyperammonemia is reversed by splenectomy. These studies show that hepatocytes can be conditionally immortalized, expanded in culture, and are capable of providing metabolic support in chronic liver insufficiency. Safeguards that could make these cells clinically useful can be accomplished using currently available technology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Artificial liver: A forthcoming attraction
Sussman, N. L., & Kelly, J. H. (1993) · Hepatology · doi:10.1002/hep.1840170632 · Cited by 46
Cited by
Human Hepatocyte Transplantation: Worldwide Results
Fisher, R. A., & Strom, S. C. (2006) · Transplantation · doi:10.1097/01.tp.0000231689.44266.ac · Cited by 445
Hepatocyte Transplantation for the Treatment of Human Disease
Strom, S., Chowdhury, J., & Fox, I. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007096 · Cited by 366
Self-citationPrevention of acute liver failure in rats with reversibly immortalized human hepatocytes
Kobayashi, N., Fujiwara, T., Westerman, K. A., Inoue, Y., Sakaguchi, M., Noguchi, H., Miyazaki, M., Cai, J., Tanaka, N., Fox, I. J., et al. (2000) · Science · doi:10.1126/science.287.5456.1258 · Cited by 331
Self-citationCell and tissue engineering for liver disease
Bhatia, S. N., Underhill, G. H., Zaret, K. S., & Fox, I. J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3005975 · Cited by 309
Self-citationUse of differentiated pluripotent stem cells in replacement therapy for treating disease
Fox, I. J., Daley, G. Q., Goldman, S. A., Huard, J., Kamp, T. J., & Trucco, M. (2014) · Science · doi:10.1126/science.1247391 · Cited by 291
Self-citationMitochondrial permeability transition in pH-dependent reperfusion injury to rat hepatocytes
Qian, T., Nieminen, A.-L., Herman, B., & Lemasters, J. J. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.273.6.c1783 · Cited by 258
Dedifferentiation of conditionally immortalized hepatocytes with long-term in vitro passage
Kim, B.-H., Sung, S.-R., Choi, E.-H., Kim, Y.-I., Kim, K.-J., Dong, S.-H., Kim, H.-J., Chang, Y.-W., Lee, J.-I., & Chang, R. (2000) · Experimental & Molecular Medicine · doi:10.1038/emm.2000.6 · Cited by 42
“The conditionally immortalized hepatocytes (CIH) with a gene for tsT or tumor cell lines have been employed to investigate mechanism of hepatocyte-specific differentiation (Chou, 1983; Jat et al., 1989; Fox et al., 1995) or to treat liver failure (Schumacher et al., 1996; Nakamura et al., 1997).”
BackgroundMethodSelf-citation
Metadata
- Authors
- Schumacher, I. K., Okamoto, T., Kim, B., Chowdhury, N. R., Chowdhury, J. R., & Fox, I. J.
- Venue
- Hepatology
- Published
- 1996-08
- Volume
- 24
- Issue
- 2
- Pages
- 337-343
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2026796585
- Cited by
- 73
- References
- 1
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.